Av. rating

Mastitis under control in Canada: great results after vaccination against S. uberis

 

Streptococcus uberis is one of the main mastitis pathogens, and one of the most difficult to control. Given its potential to cause a significant impact on the herd, it is crucial to stablish the most adequate strategy against it. In the following study, presented at the WBC’24 (Cancún, Mexico), they were evaluated the results obtained in two Canadian farms after vaccination against S. uberis.

 

The pathogen

Mastitis caused by S. uberis is a common and significant issue in dairy herds, impacting both animal health and farm productivity.

Preventing this problem involves several strategies, including management practices and vaccination.

“Vaccines are a helpful tool to reduce the incidence and severity of mastitis cases, by enhancing the cow’s immune response to the bacteria”.

 

Design of the study

Two farms (A and B) from Quebec participated in the study, which had a high incidence of clinical mastitis caused by S. uberis.

In both farms, the whole herd was vaccinated with UBAC®, a subunit vaccine against S. uberis. The protocol recommended by the attending practitioner was followed, consisting of 3 intramuscular doses separated by a month interval, and then they were revaccinated 6 months later.

For the periods of one year before and one year after vaccination (2020-2021), the following data was recorded monthly on each farm:

– Individual cow somatic cell count (SCC)

– Milk production

– Fat and protein

– Clinical mastitis cases

“Data was stratified based on whether the cows were primiparous or multiparous”.

 

What were the results?

FARM A

Clinical mastitis cases were reduced in the year after vaccination, especially on the multiparous group, which had a bigger margin for improvement.

Also in this group there was also a remarkable reduction in the number of positive samples for S. uberis after vaccination.

Fig 1 and 2. Results obtained in FARM A: clinical mastitis cases and productive parameters.

 

FARM B

In this case, there was a statistically significant reduction  of clinical mastitis in the primiparous cows.

No positive samples of S. uberis were obtained in primiparous animals after being vaccinated.

Fig 3 and 4. Results obtained in FARM B: clinical mastitis cases and productive parameters.

 

Conclusions

In this study, vaccination with UBAC® improved herd health and specifically reduced S. uberis mastitis cases on Canadian farms.

“UBAC® proves to be a powerful tool in preventing S. uberis mastitis in dairy herds”.

SEE THE STUDY

 

Article written by Tania Perálvarez Puerta. Global Product Manager, Small Ruminants Franchise – HIPRA

How useful was this information for you?:

[Total: 3   Average: 5/5]

RELATED POSTS

NEWSLETTER

DON’T MISS ANY UPDATES ON MASTITIS VACCINATION

    I have read and agree to the Privacy Policy and Basic information on Data Protection.

    ASK THE EXPERTS

    Your opinion is very important to us, so we encourage you to contact our team of experts on Mastitis Vaccination to ask any questions or discuss any concerns you may have about mastitis.


      I have read and agree to the Privacy Policy and Basic information on Data Protection.


      DISCOVER THE QUICK TALKS !

      Subscribe to our newsletter and be updated with the latest STREAMING COURSES & VIDEO-WEBINARS on bovine mastitis!


        I have read and agree to the Privacy Policy and Basic information on Data Protection.

        Basic Personal Data Protection information: Controller: LABORATORIOS HIPRA, S.A. Purposes: Managing the contractual and/or business relationship with HIPRA, including sending news, promotions and invitations to events sponsored by HIPRA. Lawful basis: Performance of the contractual relationship and HIPRA’s legitimate Interest. Recipients: Third parties to which HIPRA has entrusted cloud computing, security, auditing, mailing, technical and computer support services, as well as companies in its group. Rights: Request access to and rectification or erasure of personal data and other rights as explained in the additional information. You can seeview the detailed additional information about data protection in our Privacy Policy. For further information, please check our detailed information on Data Protection.

        Website for veterinarians

        The contents of this website are aimed exclusively at prescribing veterinarians. By clicking on Accept you state that you are a veterinary professional. In other case, please contact a veterinarian and click on Decline.

        Basic Personal Data Protection information:

        Controller: LABORATORIOS HIPRA, S.A.
        Purposes: Managing the contractual and/or business relationship with HIPRA, including sending news, promotions and invitations to events sponsored by HIPRA.
        Lawful basis: Performance of the contractual relationship and HIPRA’s legitimate Interest.
        Recipients: Third parties to which HIPRA has entrusted cloud computing, security, auditing, mailing, technical and computer support services, as well as companies in its group.
        Rights: Request access to and rectification or erasure of personal data and other rights as explained in the additional information. You can seeview the detailed additional information about data protection in our Privacy Policy.

        For further information, please check our detailed information on Data Protection.